Julie Hambleton's Net Worth

$1.2 Million

Estimate Recalculated Sep 17, 2024 07:59PM EST

Who is Julie Hambleton?

Julie Hambleton has an estimated net worth of $1.2 Million. This is based on reported shares across multiple companies, which include Erasca, Inc., IGM Biosciences, Inc., IDEAYA Biosciences, Inc., SpringWorks Therapeutics, Inc., and FIVE PRIME THERAPEUTICS INC.

SEC CIK

Julie Hambleton's CIK is 0001578771

Past Insider Trading and Trends

2015 was Julie Hambleton's most active year for acquiring shares with 5 total transactions. Julie Hambleton's most active month to acquire stocks was the month of April. 2015 was Julie Hambleton's most active year for disposing of shares, totalling 6 transactions. Julie Hambleton's most active month to dispose stocks was the month of May. 2015 saw Julie Hambleton paying a total of $206,280.00 for 179,980 shares, this is the most they've acquired in one year. In 2015 Julie Hambleton cashed out on 45,108 shares for a total of $800,237.64, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Erasca, Inc. (ERAS) Snapshot price: $2.86

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 20
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jun 22
Form 4
∞
6K
$16.00
$96,000.00
6K
Jul 20
Form 3
—
0
—
—
0
No matching records found

IGM Biosciences, Inc. (IGMS) Snapshot price: $10.17

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 12
Form 4
—
0
—
—
0
Apr 4
Form 4
—
0
—
—
0
Mar 12
Form 4
-33.33%
-1.00K
$80.00
-$80,000.00
2K
Scheduled
Aug 9
Form 4
-40.00%
-2.00K
$80.00
-$160,000.00
3K
Scheduled
Jun 1
Form 4
—
0
—
—
0
Feb 19
Form 4
—
0
—
—
0
Feb 5
Form 4
∞
5K
$18.31
$91,550.00
5K
Sep 18
Form 4
—
0
—
—
0
Sep 17
Form 3
—
0
—
—
0
No matching records found

IDEAYA Biosciences, Inc. (IDYA) Snapshot price: $36.21

SVP, Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 21
Form 3
—
0
—
—
0
No matching records found

SpringWorks Therapeutics, Inc. (SWTX) Snapshot price: $38.75

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-53.16%
-4.65K
$40.03
-$186,047.96
4.09K
Scheduled
Jun 3
Form 4
+88.10%
4.09K
—
—
8.74K
May 16
Form 4
-34.22%
-2.42K
$29.31
-$70,875.93
4.65K
Jul 19
Form 4
-25.35%
-2.40K
$26.92
-$64,603.20
7.07K
Jun 20
Form 4
+96.47%
4.65K
—
—
9.47K
May 24
Form 4
-18.67%
-1.11K
$31.50
-$34,841.32
4.82K
Mar 15
Form 4
+435.62%
4.82K
—
—
5.92K
May 19
Form 4
+22.62%
1.11K
—
—
6K
May 20
Form 4
—
0
—
—
0
May 20
Form 3
—
0
—
—
0
No matching records found

FIVE PRIME THERAPEUTICS INC No price found

EVP & Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-1.29%
-1.11K
$22.01
-$593,957.64
84.81K
Nov 11
Form 4
∞
1.76K
$13.07
$22,026.80
1.76K
Sep 18 - Aug 22
Form 4
+698.32%
75K
—
—
85.74K
Aug 20
Form 4
—
0
—
—
0
Aug 17
Form 4
+399.20%
7.98K
—
—
9.98K
Apr 30
Form 4
—
0
—
—
0
Aug 22
Form 3
—
0
—
—
0
No matching records found